Classic Congenital Adrenal Hyperplasia Clinical Trials
10 clinical trials for Classic Congenital Adrenal Hyperplasia across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia — RECRUITING · PHASE3
- A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) — RECRUITING · PHASE2
- An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia — RECRUITING · PHASE2
- A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants with Congenital Adrenal Hyperplasia Including a Long-Term Extension — TERMINATED · PHASE3
- A Phase 3b, Open-Label Study of Crinecerfont to Evaluate Androgen Reduction and Related Outcomes in Adults With Classic Congenital Adrenal Hyperplasia — NOT_YET_RECRUITING · PHASE3
- A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants with Classic Congenital Adrenal Hyperplasia — TERMINATED · PHASE3
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment — TERMINATED · PHASE3
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment — TERMINATED · PHASE3
- Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) — COMPLETED · PHASE2
- Fertility and Pregnancy in Patients With Classic Congenital Adrenal Hyperplasia — COMPLETED
Refine this search